News for Amgen Inc. (AMG.DE)

Amgen Inc. (NASDAQ:AMGN) Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 9:20 PM ETCompany ParticipantsJames E.

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.

Amgen Inc.

Amgen's Breakthrough: Interim results from Amgen's Phase III trial show Imdelltra significantly improving survival rates in small cell lung cancer. Anal

Summary Amgen Inc (AMGN) has announced promising interim results from its global Phase 3 DeLLphi-304 trial, revealing that IMDELLTRA® (tarlatamab-dlle) signifi

Amgen (AMGN) has revealed promising interim findings from its global Phase 3 DeLLphi-304 study. The trial demonstrated that IMDELLTRA significantly lowered the

**media[642718]**

Summary Amgen Inc (AMGN), a leading biotechnology company, announced on May 30, 2025, that it will be presenting at the Jefferies Global Healthcare Conference o

Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), GE Aerospace (GE) and Amgen Inc. (AMGN).

Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.

Piper Sandler has adjusted its price target for Amgen (AMGN), lowering it slightly to $328 from the previous $329, while maintaining an Overweight rating on the

Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent® (alirocumab) from c

**media[627485]**

Amgen Inc. (NASDAQ:AMGN) BofA Securities 2025 Healthcare Conference Call May 14, 2025 12:20 PM ETCompany ParticipantsPeter Griffith - Executive Vice...

Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.

What Happened: On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the

Insights from the First Quarter of 2025 PRIMECAP Management (Trades, Portfolio) recently submitted its 13F filing for the first quarter of 2025, offering a gli

**media[620337]**